Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGY) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 900 shares, a decrease of 88.9% from the February 28th total of 8,100 shares. Based on an average daily volume of 129,800 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Merck KGaA Stock Performance

Shares of OTCMKTS:MKKGY traded down $1.03 during trading hours on Wednesday, hitting $27.23. The stock had a trading volume of 47,833 shares, compared to its average volume of 126,469. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The stock’s fifty day simple moving average is $29.18 and its 200 day simple moving average is $31.07. The firm has a market capitalization of $17.60 billion, a price-to-earnings ratio of 16.81, a PEG ratio of 2.05 and a beta of 0.98. Merck KGaA has a 1-year low of $27.19 and a 1-year high of $39.17.

Merck KGaA (OTCMKTS:MKKGY) last posted its earnings results on Thursday, March 6th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. The firm had revenue of $5.78 billion for the quarter, compared to analysts’ expectations of $5.40 billion. Sell-side analysts anticipate that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.